|
시장보고서
상품코드
2053251
흡입 마취 시장 : 제품별, 용도별, 최종 사용자별 및 지역별Inhalation Anesthesia Market, By Product, By Application, By End Users, and By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
흡입 마취 시장은 2026년에 15억 6,520만 달러로 추계되고 있으며, 2033년까지 22억 7,690만 달러에 이를 전망입니다. 2026-2033년 CAGR 5.5%를 나타낼 것으로 예측됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준연도 : | 2025년 | 시장 규모 : 2026년 | 15억 6,520만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간 CAGR : 2026-2033년 | 5.50% | 시장 규모 예측 : 2033년 | 22억 7,690만 달러 |
흡입 마취(아산화질소, 할로탄, 이소플루란, 데스플루란, 세보플루란 등) (현재 임상 현장에서 가장 널리 사용되는 약제)는 수술실에서 전신 마취를 유도하고 유지하는 데 사용됩니다. 흡입 마취는 마취 상태를 보다 정밀하게 조절할 수 있고, 비용도 저렴하게 운영할 수 있어 마취 유지에 널리 사용됩니다.
시장 역학
예를 들어, 2022년 8월, 종합병원용 제네릭 의약품 분야의 주요 기업인 Piramal Pharma Limited의 중환자 치료 사업부는 황산아연 주사제의 미국 내 ‘최초 출시(First-to-Market)’ 제네릭 의약품 출시를 발표했습니다. 본 제품은 미국 식품의약국(FDA)으로부터 ‘경쟁적 제네릭 요법(CGT)’으로 지정되어 승인되었습니다. 이는 독점 공급 의약품 시장 경쟁을 촉진하기 위한 승인 절차입니다. 이 주사제는 30mg/10mL(3mg/mL) 및 25mg/5mL(5mg/mL) 용량으로 제공됩니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트도 제공합니다.
- 본 조사에서는 기업의 주요 정보, 제품 포트폴리오, 주요 성과, 재무 실적, 전략 등의 지표를 바탕으로 전 세계 흡입 마취 시장의 주요 기업 프로파일을 작성하고 있습니다.
- 본 보고서의 분석 결과를 바탕으로, 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 흡입 마취 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 흡입 마취 시장을 분석하는 데 사용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 흡입 마취 시장 : 제품별(2021-2033년)
제5장 세계의 흡입 마취 시장 : 용도별(2021-2033년)
제6장 세계의 흡입 마취 시장 : 최종 사용자별(2021-2033년)
제7장 세계의 흡입 마취 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
AJYInhalation Anesthesia Market is estimated to be valued at USD 1,565.2 Mn in 2026 and is expected to reach USD 2,276.9 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,565.2 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.50% | 2033 Value Projection: | USD 2,276.9 Mn |
Inhalation anesthetics (such as nitrous oxide, halothane, isoflurane, desflurane, and sevoflurane; most commonly used agents in practice today) are used for induction and maintenance of general anesthesia in the operating room. Inhaled anesthetics are preferred for maintenance of anesthesia because they allow a more precise control of the anesthetic state and do so at low cost.
Market Dynamics
For instance, in August 2022, Piramal Pharma Limited's Critical Care business, a leading Complex Hospital Generics company, announced the First to Market Generic U.S. launch of the Zinc Sulfate Injection. This product is U.S. Food and Drug Administration approved with Competitive Generic Therapy (CGT) designation; an approval pathway intended to enhance market competition for sole source drugs. The injection is available in 30mg/10mL (3mg/mL) and 25mg/5mL (5mg/mL).
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global inhalation anesthesia market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Abbvie Inc., Novartis AG, Piramal Enterprises Ltd., Hikma Pharmaceuticals Plc, Fresenius SE & CO. KGaA, Halocarbon Products Corporation, Baxter International Inc., Troikaa Pharmaceuticals, Ltd., Jiangsu Hengrui Medicine Co., Ltd., Lunan Pharmaceutical Group Co. Ltd., among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global inhalation anesthesia market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhalation anesthesia market.
Market Segmentation
- Global Inhalation Anesthesia Market, By Product (Revenue, USD Mn, 2021 - 2033)
- Sevoflurane
- Desflurane
- Isoflurane
- Nitrous Oxide
- Global Inhalation Anesthesia Market, By Application (Revenue, USD Mn, 2021 - 2033)
- Induction
- Maintenance
- Global Inhalation Anesthesia Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Ambulatory Surgical Centers
- Global Inhalation Anesthesia Market, By Geography (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Abbvie Inc.
- Novartis AG
- Piramal Enterprises Ltd.
- Hikma Pharmaceuticals Plc
- Fresenius SE & CO. KgaA
- Baxter International Inc.
- Troikaa Pharmaceuticals, Ltd.
- Halocarbon Products Corporation
- Jiangsu Hengrui Medicine Co., Ltd.
- Lunan Pharmaceutical Group Co. Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- High burden of chronic disease and growing geriatric population
- Side-effects and rise in demand or adoption of generic drugs
- Increasing demand or use of novel inhalation anesthetic drugs
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Inhalation Anesthesia Market, By Product, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Sevoflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Desflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Isoflurane
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Nitrous Oxide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
5. Global Inhalation Anesthesia Market, By Application, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Induction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Maintenance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Global Inhalation Anesthesia Market, By End User, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
7. Global Inhalation Anesthesia Market, By Geography, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
8. Competitive Landscape
- Abbvie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Piramal Enterprises Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hikma Pharmaceuticals Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fresenius SE & CO. KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Troikaa Pharmaceuticals, Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Halocarbon Products Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jiangsu Hengrui Medicine Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lunan Pharmaceutical Group Co. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
